Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 73 (CCDC73), also known as sarcoma antigen NY-SAR-79, is a poorly characterized human protein containing a coiled-coil domain. Its biological function remains unknown, with no experimental evidence confirming a specific role in cellular processes or disease mechanisms. Although initially identified in the context of sarcoma and grouped among cancer testis antigens, there are no current data to support its use as a therapeutic target or biomarker. No drugs are known to interact with this protein, and it is not recognized as a member of any well-defined molecular family such as receptors, enzymes, or transcription factors
None established (no approved or experimental therapeutics known to target this protein specifically)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 73 (CCDC73).